Graphene Investments SAS’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.6M Sell
3,000
-200
-6% -$204K 2.1% 18
2026
Q1
$2.94M Hold
3,200
1.98% 32
2025
Q4
$3.44M Sell
3,200
-1,000
-24% -$956K 2.16% 16
2025
Q3
$3.2M Hold
4,200
2.03% 23
2025
Q2
$3.27M Buy
4,200
+1,100
+35% +$855K 2.13% 13
2025
Q1
$2.56M Sell
3,100
-1,000
-24% -$832K 1.87% 36
2024
Q4
$3.17M Buy
4,100
+800
+24% +$662K 2.19% 7
2024
Q3
$2.92M Sell
3,300
-300
-8% -$270K 1.88% 38
2024
Q2
$3.26M Sell
3,600
-600
-14% -$480K 2.05% 20
2024
Q1
$3.27M Sell
4,200
-400
-9% -$285K 1.97% 29
2023
Q4
$2.68M Sell
4,600
-600
-12% -$350K 1.74% 43
2023
Q3
$2.79M Sell
5,200
-1,800
-26% -$928K 1.96% 31
2023
Q2
$3.28M Sell
7,000
-2,800
-29% -$1.17M 2.16% 9
2023
Q1
$3.37M Buy
9,800
+800
+9% +$270K 2.25% 5
2022
Q4
$3.29M Buy
+9,000
New +$3.19M 2.23% 8

Other funds holding LLY

Graphene Investments SAS's LLY Position: Q2 2026 in Review

Graphene Investments SAS reduced its Eli Lilly (LLY) stake by 6.3% in Q2 2026, selling an estimated $204K and leaving 3,000 shares worth $3.6M. The position accounts for 2.1% of the portfolio, ranked #18.

Graphene Investments SAS first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 2,373 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Graphene Investments SAS held 3,000 shares of Eli Lilly worth $3.6M as of Q2 2026.
  • Graphene Investments SAS sold 200 Eli Lilly shares in Q2 2026, an estimated $204K.
  • Eli Lilly made up 2.1% of Graphene Investments SAS's portfolio in Q2 2026, its #18 holding.
  • Graphene Investments SAS first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 2,373 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Graphene Investments SAS's 13F filing for Q2 2026, filed 20 Jul 2026.